No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study

ABSTRACTTo assess tocilizumab (TCZ) efficacy associated to standard of care (SOC) compared to SOC alone in severe coronavirus associated disease 2019 (COVID-19) patients. In a matched case-control study from 3 French Hospital COVID-19 Departments, 27 patients with severe COVID-19 treated with TCZ an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2021-05, Vol.100 (21), p.e26023-e26023
Hauptverfasser:	Burlacu, Ruxandra, London, Jonathan, Fleury, Audrey, Sené, Thomas, Diallo, Abdourahmane, Meyssonnier, Vanina, Zeller, Valérie, Galland, Joris, Huscenot, Tessa, Rubenstein, Emma, Trouiller, Pierre, Amathieu, Roland, Kutter, Johannes, Blondeel, David, Lejour, Gabriel, Mouly, Stéphane, Lidove, Olivier, Wladimir, Mauhin, Sène, Damien
Format:	Artikel
Sprache:	eng
Schlagworte:	Observational Study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!